ClinConnect ClinConnect Logo
Search / Trial NCT05804344

Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning

Launched by NEW YORK UNIVERSITY · Apr 6, 2023

Trial Information

Current as of August 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different types of brain stimulation might help with learning to produce new speech sounds. Participants will practice saying made-up words, and researchers will compare the effects of various stimulation methods on their speech abilities. These methods include using anodal or cathodal stimulation on specific parts of the brain related to speech and motor control, as well as a "sham" version that doesn’t provide any real stimulation. The goal is to understand whether stimulating certain brain areas is important for learning to speak more accurately, which could eventually help people with speech difficulties.

To participate, individuals need to be native English speakers who haven’t been exposed to certain other languages that include similar sounds. They should not have any history of speech, language, or hearing disorders and must pass a hearing test. Participants will engage in speech training sessions, and they will be monitored to see how well they learn to produce the new sounds. This study is a great opportunity for healthy adults aged 18 to 65 who meet the criteria and want to contribute to research that could benefit people with speech impairments in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • native English speaker (learned English in the home from birth)
  • no exposure to languages that contain the trained consonant clusters (e.g., Slavic languages, Greek, Hebrew).
  • Exclusion Criteria:
  • a history of speech, language or hearing disorder
  • not passing a hearing screening (40 dB HL; ANSI: 1983) at 500, 1000, 2000, 4000Hz binaurally
  • presence of potential tDCS risk factors: damaged skin at site of stimulation; presence of electrically or magnetically activated implant (including pacemaker); and metal in any part of their body

About New York University

New York University (NYU) is a prestigious research institution renowned for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure and a diverse team of leading experts, NYU conducts cutting-edge research across various therapeutic areas, focusing on translating scientific discoveries into effective treatments. The university fosters collaboration among multidisciplinary teams and engages with a broad patient population, ensuring that its trials adhere to the highest ethical standards and regulatory requirements. NYU's dedication to excellence in research and education positions it as a key contributor to the advancement of healthcare and clinical practice.

Locations

New York, New York, United States

Patients applied

0 patients applied

Trial Officials

Adam Buchwald, PhD

Principal Investigator

New York University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials